# Program 11 Readiness Report
**CyberCom Platform — Based on Program 10 Completion**  
**Date:** 2026-06-29  
**Classification:** Internal — Release Planning  
**Roles:** CTO, CIO, CMIO, Release Manager, Engineering Leads

---

## Purpose

This report assesses CyberCom Platform's readiness to begin Program 11 following completion of Program 10. It defines the pre-conditions for Program 11 commencement and recommends scope based on current state.

---

## Program 10 Completion Confirmation

| Phase | Name | Status |
|-------|------|--------|
| 1 | Security Audit & Validation | ✅ COMPLETE |
| 2 | Clinical Safety Validation | ✅ COMPLETE |
| 3 | Performance & Reliability | ✅ COMPLETE |
| 4 | Customer Pilot Package | ✅ COMPLETE |
| 5 | Implementation Validation | ✅ COMPLETE |
| 6 | Operational Readiness | ✅ COMPLETE |
| 7 | Documentation | ✅ COMPLETE |

**Program 10 Status: COMPLETE ✅**

---

## Technical Debt & Stability Baseline

| Metric | Value | Status |
|--------|-------|--------|
| Test suite | 1269 passing, 0 failing | ✅ GREEN |
| Code coverage | 87.18% (threshold: 80%) | ✅ GREEN |
| Security tests | 26/26 passing | ✅ GREEN |
| Clinical safety tests | 17/17 passing | ✅ GREEN |
| Drug interaction tests | 7/7 passing | ✅ GREEN |
| TypeScript typecheck (website) | 0 errors | ✅ GREEN |
| Open critical bugs | 0 known | ✅ GREEN |
| Open security vulnerabilities | 0 known (pending pen test) | ⚠️ UNVERIFIED |

---

## Program 11 Pre-Conditions

### Required Before Program 11 Kickoff

| Pre-Condition | Status | Owner |
|---------------|--------|-------|
| Program 10 completion report signed | ✅ COMPLETE | Release Manager |
| First pilot customer identified | Must be confirmed | CCO |
| Pilot deployment environment provisioned | Must be provisioned | Customer IT + DevOps |
| Drug DB licensing initiated (if pharmacy) | Must be initiated | CIO |
| Pen test engagement booked | Must be booked | CISO |

### Recommended Before Program 11 Mid-Point

| Pre-Condition | Status | Owner |
|---------------|--------|-------|
| First pilot go-live | During P11 | Pilot Lead |
| Post-go-live feedback collected | During P11 | Customer Success |
| SOC 2 Type II observation period started | Q3/Q4 2026 | CCO |

---

## Recommended Program 11 Scope

Based on Program 10 completion state, Program 11 should focus on:

### Track 1: First Pilot Execution (Mandatory)

| Objective | Description |
|-----------|-------------|
| Pilot deployment | Execute `deploy_pilot.sh` at first customer site |
| Hypercare (Days 1–30) | Dedicated support, daily check-ins, 30-min critical SLA |
| UAT execution | Complete UAT scenarios from `uat_scenarios.py` |
| Customer acceptance | Complete `Customer_Acceptance_Report.md` |
| Post-pilot retrospective | Document findings for product roadmap |

### Track 2: Security Hardening (Mandatory)

| Objective | Description |
|-----------|-------------|
| External penetration test | Engage qualified firm, remediate findings |
| Dependency vulnerability scan | pip-audit + Snyk on Python deps |
| Container security scan | Trivy/Grype on all Docker images |
| CI/CD secret scanning | gitleaks in pipeline |
| OPA policy review | External review of authorization policies |

### Track 3: Operational Maturity (Recommended)

| Objective | Description |
|-----------|-------------|
| Monitoring dashboards | Grafana dashboards for API latency, error rate, DB |
| Alerting rules | PagerDuty/OpsGenie P1 alert setup |
| Log aggregation | ELK stack or Grafana Loki for log centralization |
| Backup automation | Automated daily backup + restore verification |
| DR runbook | Documented and tested disaster recovery procedure |
| Load testing | Run `load_test_scenarios.py` against pilot environment |

### Track 4: Feature Development (If Capacity Allows)

| Candidate Feature | Priority | Dependencies |
|-------------------|----------|-------------|
| Patient portal (self-service) | HIGH | Pilot feedback |
| Telemedicine integration | HIGH | Customer demand |
| Advanced analytics / reporting | MEDIUM | Data warehouse |
| Mobile app (CyMed Mobile) | MEDIUM | UX design complete |
| Billing / revenue cycle | LOW | Partner ecosystem |
| Government portal integration | MEDIUM | Market-specific |

---

## Architecture Constraints for Program 11

| Constraint | Reason |
|------------|--------|
| No breaking changes to `BaseModel` or `PlatformModel` | All domain models extend these; migrations affect all tenants |
| No changes to audit immutability (`AuditLog.save()`, `AuditEvent.save()`) | ADR-0028 compliance |
| All AI outputs must remain advisory-only | `GuardrailPolicy.policy_type = "clinical_safety"` must stay enforced |
| Drug interaction override must always require pharmacist UUID | `overridden_by` non-null invariant |
| Tenant isolation cannot be relaxed | Any cross-tenant visibility = P1 security defect |
| No force push to main or develop | Branch protection; all changes via PR + review |

---

## Program 11 Readiness Verdict

| Category | Status |
|----------|--------|
| Software baseline | ✅ READY |
| Test suite stability | ✅ READY |
| Documentation | ✅ READY |
| Pilot package | ✅ READY |
| External pre-conditions | ⚠️ ACTIONS REQUIRED (see External Blockers Report) |
| **Overall** | **✅ READY TO BEGIN PROGRAM 11** |

**Program 11 can begin as soon as the first pilot customer is confirmed and their environment is provisioned.**  
External blockers (drug DB, pen test, regulatory filings) should run in parallel with Program 11 engineering work.

---

## Program 11 Recommended Start Gate

| Gate | Condition |
|------|-----------|
| MUST | Program 10 complete ✅ |
| MUST | First pilot customer contracted or LOI signed |
| MUST | Pen test engagement booked (CISO action) |
| SHOULD | Pilot environment provisioned and accessible |
| NICE TO HAVE | Drug DB licensing terms agreed |

**Authorized by:** Release Manager · CTO · CMIO  
**Date:** 2026-06-29
